Skip to main content
21+Industry intelligence — not direct nicotine sales
Regulation & Policy

Guidance: Antidepressants: use and safety

Summary: Guidance on the use and side effects of selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs), their safety, use in pregnancy and the risk of suicidal behaviour.

Guidance on the use and side effects of selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs), their safety, use in pregnancy and the risk of suicidal behaviour.

Adults 21+. WINDBAR does not sell nicotine products on this site. Compliance statement.

← Back to Regulation & Policy

Guidance: Antidepressants: use and safety | WINDBAR News